Developing new methods to create complex bioactive molecules for cancer and infectious disease treatment
Official title: New Methods and Strategies for the Scalable Synthesis of Complex Bioactive Molecules
Funded at University of Texas Dallas · NIH-11143171 · Data updated 2026-11-12
This study is working on new ways to create special molecules that could help make better medicines for cancer, brain disorders, and infections, with the hope that these advancements will lead to new treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Dallas NIH-funded |
| Lab location | 1 site (Richardson, United States) |
| Project start | August 1, 2024 |
| Project end | May 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $390,000 |
| NIH project number | 5R35GM154682-02 |
| Project ID | NIH-11143171 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with cancer, neurological disorders, or infectious diseases who may benefit from novel therapeutic approaches.
✕Less likely to help
Patients with conditions unrelated to cancer or infectious diseases may not receive direct benefits from this research.
What this research studies
This research focuses on creating innovative methods for synthesizing complex bioactive molecules that could be used in treating cancer, neurological disorders, and infectious diseases. By exploring the rapid assembly of polycyclic frameworks with multiple chiral centers, the team aims to produce both natural and synthetic compounds that have therapeutic potential. The project seeks to overcome existing challenges in accessing these compounds, which are crucial for drug development, by developing new chemical transformations and synthesis techniques. Patients may benefit from the eventual development of new medications derived from these complex molecules.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for cancer and infectious diseases.
How similar studies have gone: Previous research has shown promise in developing new synthesis methods for bioactive compounds, indicating potential success for this innovative approach.
Where this research is happening
-
University of Texas Dallas
Richardson, United States Active
Researchers
- Principal investigator: Romiti, Filippo — University of Texas Dallas
- Study coordinator: Romiti, Filippo
Related research
Other NIH-funded projects on the same topics.
-
Profilin as a Target to Normalize Tumor Vessels in Kidney Cancer
A new approach aims to curb blood vessel growth in a common kidney cancer by targeting a protein called Profilin 1 to improve how blood vessels form in tumors.
-
Ultrafast debinding for chairside 3D-printed zirconia dental restorations
A new ultrafast debinding method aims to dramatically shorten how quickly chairside 3D-printed zirconia dental crowns can be made.
-
Adolescents learning about themselves through friends and how it links to mood
A study with teens will test how feedback from close friends and strangers shapes their self-views and mood, using brain and behavior measurements.
-
Bilingual children with developmental language disorder: how two languages shape brain development
A study with bilingual kids who have developmental language disorder to see how knowing two languages affects their brain and language skills.
-
BET inhibitors as a potential therapy for solitary fibrous tumor (SFT)
Aimed at adults with solitary fibrous tumor, this grant explores BET inhibitors to block tumor-driving gene activity.
-
Estrogen, puberty, and early signs of psychosis in teens
This grant looks at how rising estrogen during puberty in girls may influence early brain changes and psychotic-like experiences as kids become teens.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.